Computational nanomedicine: Modeling of nanoparticle-mediated hyperthermal cancer therapy

Nanomedicine

Volumn 8, Issue 8, 2013, Pages 1323-1333

  Kaddi, Chanchala D ^a   Phan, John H ^a   Wang, May D ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

bioinformatics; drug delivery; hyperthermia; mathematical modeling; nanomedicine; nanoparticle; pharmacokinetics; simulation

Indexed keywords

GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE;

CANCER THERAPY; CASE STUDY; COMPARATIVE STUDY; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; MODEL; NANOMEDICINE; PRIORITY JOURNAL; REVIEW;

DRUG DELIVERY SYSTEMS; GOLD; HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS; METAL NANOPARTICLES; NANOMEDICINE; NEOPLASMS;

EID: 84893171044     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.117     Document Type: Review

References (73)

1. De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 3(2), 133-149 (2008
2. Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using nanoparticle formulations -opportunities and limitations. Drug Discov. Today Technol. 9(2), e87-e95 (2011
3. Sheridan C. Proof of concept for next generation nanoparticle drugs in humans. Nat. Biotechnol. 30(6), 471-473 (2012
4. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 63, 185-198 (2012
5. Cherukuri P, Glazer ES, Curley SA. Targeted hyperthermia using metal nanoparticles. Adv. Drug Deliv. Rev. 62(3), 339-345 (2010
6. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771-782 (2008
7. Maojo V, Fritts M, De La Iglesia D et al. Nanoinformatics: A new area of research in nanomedicine. Int. J. Nanomed. 7, 3867-3890 (2012
8. Saeys Y, Inza I, Larranaga P. A review of feature selection techniques in bioinformatics. Bioinformatics 23(19), 2507-2517 (2007
9. Soneson C, Delorenzi M. A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics 14, 91 (2013
10. Chavali AK, D'Auria KM, Hewlett EL, Pearson RD, Papin JA. A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Trends Microbiol. 20(3), 113-123 (2012
11. Zhao S, Iyengar R. Systems pharmacology. Network analysis to identify multiscale mechanisms of drug action. Annu. Rev. Pharmacol. Toxicol. 52, 505-521 (2012
12. Xing Y, Chaudry Q, Shen C et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat. Protoc. 2(5), 1152-1165 (2007
13. Akbari H, Halig LV, Schuster DM et al. Hyperspectral imaging and quantitative analysis for prostate cancer detection. J. Biomed. Opt. 17(7), 076005 (2012
14. Parthasarathy R. Rapid, accurate particle tracking by calculation of radial symmetry centers. Nat. Methods 9(7), 724-726 (2012
15. Shen Z, Andersson SB. Tracking nanometer scale fluorescent particles in two dimensions with a confocal microscope. IEEE Trans. Control Syst. Technol. 19(5), 1269-1278 (2011
16. Tonkin JA, Rees P, Brown MR et al. Automated cell identification and tracking using nanoparticle moving-light-displays. PLoS One 7(7), e40835 (2012
17. Liu Y, Shah S, Tan J. Computational modeling of nanoparticle targeted drug delivery. Rev. Nanosci. Nanotechnol. 1(1), 66-83 (2012
18. Sanhai WR, Sakamoto JH, Canady R, Ferrari M. Seven key challenges for nanomedicine. Nat. Nanotechnol. 3, 242-244 (2008
19. Hossain SS, Hossainy SFA, Bazilevs Y, Calo VM, Hughes TJR. Mathematical modeling of coupled drug and drug-encapsulated nanoparticle transport in patient-specific coronary artery walls. Comput. Mech. 49(2), 213-242 (2012
20. Huynh L, Neale C, Pomes R, Allen C. Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery. Nanomedicine 8(1), 20-36 (2012
21. Gamsiz DE, Shah LK, Devalapally H, Amiji MM, Carrier RL. A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells. Biotechnol. Bioeng. 101(5), 1072-1082 (2008
22. Goodman TT, Chen JY, Matveev K, Pun SH. Spatio-Temporal modeling of nanoparticle delivery to multicellular tumor spheroids. Biotechnol. Bioeng. 101(2), 388-399 (2008
23. Kim B, Han G, Toley BJ, Kim CK, Rotello VM, Forbes NS. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 5(6), 465-472 (2010
24. Shah S, Liu YL, Hu W, Gao JM. Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 11(2), 919-928 (2011
25. Xu X, Li RB, Ma M, Wang X, Wang YH, Zou HF. Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C-60: Experiment and modeling. Soft Matter 8(10), 2915-2923 (2012
26. Fetterly GJ, Grasela TH, Sherman JW et al. Pharmacokinetic/ pharmacodynamic modeling and simulation of neutropenia during Phase I development of liposome-entrapped paclitaxel. Clin. Cancer Res. 14(18), 5856-5863 (2008
27. Lin HY, Landersdorfer CB, London D et al. Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system. PLoS Comput. Biol. 7(2), e1001073 (2011
28. Hildebrandt B, Wust P, Ahlers O et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43(1), 33-56 (2002
29. Krishnan S, Diagaradjane P, Cho SH. Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy. Int. J. Hyperthermia 26(8), 775-789 (2010
30. Milleron RS, Bratton SB: 'Heated' debates in apoptosis. Cell. Mol. Life Sci. 64(18), 2329-2333 (2007
31. Roti JLR. Cellular responses to hyperthermia (40-46 degrees C): Cell killing and molecular events. Int. J. Hyperthermia 24(1), 3-15 (2008
32. Van Der Zee J. Heating the patient: A promising approach? Ann. Oncol. 13(8), 1173-1184 (2002
33. Issels RD. Hyperthermia adds to chemotherapy. Eur. J. Cancer 44(17), 2546-2554 (2008
34. Chichel A, Skowronek J, Kubaszewska M, Kanikowski M. Hyperthermia -description of a method and a review of clinical applications. Rep. Pract. Oncol. Radiother. 12(5), 267-275 (2007
35. Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. J. Biomech. Eng. 131(7), 074001 (2009
36. Purushotham S, Ramanujan RV. Modeling the performance of magnetic nanoparticles in multimodal cancer therapy. J. Appl. Phys. 107(11), 114701 (2010
37. Huang HC, Rege K, Heys JJ. Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods. ACS Nano 4(5), 2892-2900 (2010
38. Salloum M, Ma R, Zhu L. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: Optimization of the heat absorption pattern. Int. J. Hyperthermia 25(4), 309-321 (2009
39. Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci. 166(1-2), 8-23 (2011
40. Gannon CJ, Cherukuri P, Yakobson BI et al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110(12), 2654-2665 (2007
41. Iancu C, Mocan L. Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia. Int. J. Nanomed. 6, 1675-1684 (2011
42. Johannsen M, Gneveckow U, Thiesen B et al. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 52(6), 1653-1662 (2007
43. Johannsen M, Gneveckow U, Eckelt L et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int. J. Hyperthermia 21(7), 637-647 (2005
44. Johannsen M, Gneveckow U, Taymoorian K et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective Phase I trial. Int. J. Hyperthermia 23(3), 315-323 (2007
45. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int. J. Hyperthermia 26(8), 790-795 (2010
46. Maier-Hauff K, Rothe R, Scholz R et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 81(1), 53-60 (2007
47. Maier-Hauff K, Ulrich F, Nestler D et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103(2), 317-324 (2011
48. Wust P, Gneveckow U, Johannsen M et al. Magnetic nanoparticles for interstitial thermotherapy -feasibility, tolerance and achieved temperatures. Int. J. Hyperthermia 22(8), 673-685 (2006
49. Kennedy LC, Bickford LR, Lewinski NA et al. A new era for cancer treatment: Gold-nanoparticle-mediated thermal therapies. Small 7(2), 169-183 (2011
50. Cervadoro A, Giverso C, Pande R et al. Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS One 8(2), e57332 (2013
51. Liangruksa M, Ganguly R, Puri IK. Parametric investigation of heating due to magnetic fluid hyperthermia in a tumor with blood perfusion. J. Magn. Magn. Mater. 323(6), 708-716 (2011
52. Candeo A, Dughiero F Numerical FEM models for the planning of magnetic induction hyperthermia treaements with nanoparticles IEEE Trans. Magn. 45(3), 1658-1661 (2009
53. Rast L, Harrison JG Computational modeling of electromagnetically induced heating of magnetic nanoearticle materials for hyperthermic cancer treatment Piers 6(7), 990-994 (2010
54. Stigliano RV, Shubitidze F, Petryk AA, Tate JA, Hoopes PJ. Magnetic nanoparticle hyperthermia: Predictive model for temperature distribution. Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII 858410, doi:10.1117/1112.2007673 (2013) (Online
55. Mehdaoui B, Meffre A, Carrey J et al. Optimal size of nanoparticles for magnetic hyperthermia: A combined theoretical and experimental study. Adv. Funct. Mater. 21(23), 4573-4581 (2011
56. Sawyer CA, Habib AH, Miller K, Collier KN, Ondeck CL, McHenry ME. Modeling of temperature profile during magnetic thermotherapy for cancer treatment. J. Appl. Phys. 105(7), 07B320 (2009
57. Pavel M, Stancu A. Study of the optimum injection sites for a multiple metastases region in cancer therapy by using MFH. IEEE Trans Magn. 45(10), 4825-4828 (2009
58. Xu RZ, Yu H, Zhang Y et al. Three dimensional model for determining inhomogeneous thermal dosage in a liver tumor during arterial embolization hyperthermia incorporating magnetic nanoparticles. IEEE Trans Magn. 45(8), 3085-3091 (2009
59. Mital M, Tafreshi HV. A methodology for determining optimal thermal damage in magnetic nanoparticle hyperthermia cancer treatment. Int. J. Numer. Method Biomed. Eng. 28(2), 205-213 (2012
60. Fasla B, Benmouna R, Benmouna M. Modeling of tumor's tissue heating by nanoparticles. J. Appl. Phys. 108(12), 124703 (2010
61. Letfullin RR, Iversen CB, George TF. Modeling nanophotothermal therapy: Kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. Nanomedicine 7(2), 137-145 (2011
62. Sassaroli E, Li KCP, O'Neill BE. Numerical investigation of heating of a gold nanoparticle and the surrounding microenvironment by nanosecond laser pulses for nanomedicine applications. Phys. Med. Biol. 54(18), 5541-5560 (2009
63. Cheong SK, Krishnan S, Cho SH. Modeling of plasmonic heating from individual gold nanoshells for near-infrared laser-induced thermal therapy. Med. Phys. 36(10), 4664-4671 (2009
64. Letfullin RR, George TF. Nanomaterials in nanomedicine. In: Computational Studies of New Materials II: From Ultrafast Processes and Nanostructures to Optoelectronics, Energy Storage and Nanomedicine. George TF, Jelski D, Letfullin RR, Zhang G (Eds). World Scientific, Singapore, 103-129 (2011
65. Letfullin RR, Rice CEW, George TF. Theoretical study of bone cancer therapy by plasmonic nanoparticles. Ther. Deliv. 2(10), 1259-1273 (2011
66. Bae YH, Park K. Targeted drug delivery to tumors: Myths, reality and possibility. J. Control. Release 153(3), 198-205 (2011
67. Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int. J. Hyperthermia 24(6), 451-466 (2008
68. Stamatakos GS, Georgiadi EC, Graf N, Kolokotroni EA, Dionysiou DD. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model. PLoS One 6(3), e17594 (2011
69. O'Neill DP, Peng TY, Stiegler P et al. A three-state mathematical model of hyperthermic cell death. Ann. Biomed. Eng. 39(1), 570-579 (2011
70. Rylander MN, Feng YS, Zimmermann K, Diller KR. Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells. Int. J. Hyperthermia 26(8), 748-764 (2010
71. Ruenraroengsak P, Cook JM, Florence AT. Nanosystem drug targeting: Facing up to complex realities. J. Control. Release 141(3), 265-276 (2010
72. Schluep T, Hwang J, Hildebrandt IJ et al. Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proc. Natl Acad. Sci. USA 106(27), 11394-11399 (2009
73. Hu JW, Ding YJ, Qian SY, Tang XD. Simulations of adaptive temperature control with self-focused hyperthermia system for tumor treatment. Ultrasonics 53(1), 171-177 (2013